Avaya and individual inventor Stephen Milton received a patent award in the telecommunications category for “Method and Apparatus Extending Calls to Internal Switch Extensions Out to External Network Endpoints” (U.S. Patent 6,751,309). This patent allows for phone calls to a desk or office line to be directed to a cell phone that is offsite.
BASF Corporation’s “Catalyzed SCR Filter and Emission Treatment System” (U.S. Patent 7,902,107) invented by Joseph Patchett, Joseph Dettling and Elizabeth Przybylski, received a patent award in the environmental category. Joseph Patchett and Joseph Dettling were also 2010 Thomas Alva Edison Patent Award Winners. This innovative invention is an emission treatment system that can remove harmful nitrogen oxides as well as other particulate matter from diesel engines using one single component. Existing systems use two single components to do the same thing and a technology based on this patent is scheduled for production by the end of the year.
Bristol-Myers Squibb and inventors Rajeev Bhide, Zhen-Wei Cai, Ligang Qian, Stephanie Barbosa, Louis Lombardo and Jeffrey Robl were honored with a patent award in the pharmaceutical category for “Pyrrolo[2,1-f][1,2,4]Triazine Inhibitors of Kinases” (U.S. Patent 6,869,952). Currently in Phase III clinical trials, this drug targets angiogenesis, the process of new blood vessel formation, which is essential for tumor growth.
Celgene and single inventor Robert Hariri was honored in the biomaterials category for “Tissue Matrices Comprising Placental Stem Cells, and Methods Making the Same” (U.S. Patent 7,914,779). His invention relates specifically to a method of making human tissue, such as heart tissue, by seeding a decellularized or synthetic tissue matrix with novel stem cells obtained from a placenta. This invention also allows for a method of repairing or replacing diseased and/or damaged tissue with the decellularized or synthetic tissue that was engineered.
Dr. Herman J. Saatkamp, Jr. (Educator of the Year Award)
ExxonMobil Research and Engineering Company and inventors Kevin Furman, Gary Kocis, Michael McDonald, Chad Reiman, Jin-Hwa Song (who has since left the company), and Philip Warrick were selected for a patent award for “System for Optimizing Bulk Production Allocation, Transportation, and Blending” (U.S. Patent 7,797,205) in the industrial processes category. The invention will open the doors for related inventions in the space of mathematical modeling and decision supports tools to come about.
Honeywell International Inc. and inventing duo Brian Gibson and Fred Durrenberger were recognized in the materials technology category for “Extrudable PVC Compositions” (U.S. Patent 7,645,819). This invention utilizes the molecule sucrose octastearate as a highly efficient lubricant in PVC articles. Made from renewable raw materials, this lubricant is more effective and will lower overall production costs when compared with traditional lubricants.
Immunomedics and co-inventors Drs. William J. McBride and David M. Goldenberg received a patent award in the medical imaging category for “Methods and Compositions For Improved F-18 Labeling of Proteins, Peptides and Other Molecules” (U.S. Patent 7,597,876). This invention is a novel method of labeling peptides with the diagnostic radioisotope fluorine-18 for use in the imaging of diseases with increased specificity and selectivity.
Merck & Co. (Science and Technology Medal Award)
New Jersey Institute of Technology’s “Thermoset Epoxy Polymers from Renewables Resources” (U.S. Patent 7,619,056) invented by Anthony East, Michael Jaffe, Yi Zhang and Luiz Catalani, received a patent award in the renewables category. The patent discloses a novel thermoset epoxy polymer that uses the bisglycidyl ethers of anhydrosugars (isosorbide, isomannide, and isoidide) as a substitute for bisphenol A. These anhydrosugars are derived from renewable sources.
Novartis Pharmaceuticals Corporation, along with inventors Wen-Chung Shieh and John Carlson, were recognized in the pharmaceutical process category for “Method of Manufacture of (-)-Galanthamine in High Yield and Purity Substantially Free of Epigalanthamine” (U.S. Patent 5,428,159). This invention provides an economical, environmentally friendly and practical chemical synthesis for the manufacture of the natural alkaloid, (-)-galanthamine. (-)-Galanthamine is the pharmaceutical active ingredient of several Alzheimer therapeutics.
Rep. Rodney P. Frelinghuysen (Chairman’s Award)
Rutgers, The State University of New Jersey was recognized in the manufacturing category for “Technology for Continuous Folding Sheet Materials” (U.S. Patent 7,115,089), invented by Basily B. Basily, Elsayed A. Elsayed, and Daniel Kling. This invention uses a machine to create a three dimensional structure that can be used for many different applications. Among the materials that can be used are paper, aluminium, copper and plastic. Rutgers University is currently collaborating with the United States Army on the utility of this patent.
Siemens Corporation and inventors Yefeng Zheng, Adrian Barbu (who has since became professor at Florida State University), Bogdan Georgescu, Michael Scheuering, and Dorin Comaniciu received a patent award in the information technology category for “System and Method for Segmenting Chambers of a Heart in a Three Dimensional Image” (U.S. Patent 7,916,919). With the tremendous advances in all major medical imaging modalities in the last decade, 3D images with high spatial and temporal resolution are routinely captured in daily clinical practice, providing invaluable information for disease screening, diagnosis and therapy. The patent is already being utilized on the market today and is significantly increasing the quality of care while reducing the procedure’s costs.
University of Medicine & Dentistry of New Jersey was recognized in the medical health category, along with inventors David Seifer and David MacLaughlin, for “Mullerian Inhibiting Substance Levels and Ovarian Response” (U.S. Patent 7,241,577). This patent allows for a method of assessing a women’s egg supply as well as predicting and monitoring a women’s response to fertility treatments. Additionally, this invention will aid in preventing the onset of ovarian hyper stimulation syndrome, which is a common complication during in vitro regimens that can be potentially life threatening.
U.S. Army Armament Research, Development and Engineering Center and inventors Thomas Kiel, Allen Brokaw, Frank Petrosillo, Katrina Tubayan, Matthew Hummers, Ryan Hooke, and Kirk Deligiannis received a patent award in the defense category for “Blast Shield for Armored Vehicle” (U.S. Patent 7,942,092). This protective shield invention was designed to easily attach, in the field, to a series of light military vehicles to provide protection from small arms weapons and blast effects. Derived from battlefield experience and critical advice from soldiers and technicians in the war zones of Iraq and Afghanistan, the Picatinny Blast Shield has been delivered to American and Coalition soldiers for use on tactical vehicles.